by Randy E. Miller | Aug 21, 2025 | FOIA, Pharmaceuticals, Politics
FOIAengine: Maker of Elevidys Targeted by 91 FOIA Requests in 19 Months As biotech firm Sarepta Therapeutics (NASD: SRPT) battles patient deaths, regulatory action, and a cratering stock price, its dealings with the Food and Drug Administration are being monitored...
by Randy E. Miller | Jul 24, 2025 | FOIA, News Media, Politics
FOIAengine: Requests Run the Gamut from Child Detentions to China Trade In the six months since President Trump’s inauguration, U.S. Customs and Border Protection has received hundreds of news media Freedom of Information Act requests seeking information about the...
by Randy E. Miller | Jun 25, 2025 | FOIA, News Media, Politics
FOIAengine: Journalists Use FOIA to Reveal Immigration Arrests and Contracts National and local journalists are using Freedom of Information Act requests to U.S. Immigration and Customs Enforcement to investigate the inner workings of the Trump Administration’s...
by Randy E. Miller | May 28, 2025 | FDA, FOIA, Hedge Funds, Medical Devices, Stock Market
FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped financial firms from monitoring the company’s Food and Drug Administration plant...
by Randy E. Miller | Apr 23, 2025 | FDA, FOIA, Hedge Funds, Pharmaceuticals
FOIAengine: Questions Seek Adverse Reports about Carvykti According to a new PoliScio Analytics analysis of early 2025 Freedom of Information Act requests, investment firm Point72 has launched a significant FOIA-driven investigation into Johnson &...
